Search Results
You are looking at 1 - 1 of 1 items for
- Author: Yukari Mimura x
- Refine by access: All content x
Search for other papers by Masaya Takeda in
Google Scholar
PubMed
Search for other papers by Fumio Otsuka in
Google Scholar
PubMed
Search for other papers by Hiroyuki Otani in
Google Scholar
PubMed
Search for other papers by Kenichi Inagaki in
Google Scholar
PubMed
Search for other papers by Tomoko Miyoshi in
Google Scholar
PubMed
Search for other papers by Jiro Suzuki in
Google Scholar
PubMed
Search for other papers by Yukari Mimura in
Google Scholar
PubMed
Search for other papers by Toshio Ogura in
Google Scholar
PubMed
Search for other papers by Hirofumi Makino in
Google Scholar
PubMed
Involvement of peroxisome proliferator-activated receptor-γ (PPAR-γ ) activation and bone morphogenetic protein (BMP) signaling in regulating cell proliferation and hormonal production of pituitary tumors has been reported, although the underlying mechanism remains poorly understood. Here, we investigated regulatory roles of PPARα and PPARγ in gonadotropin transcription and cell mitosis modulated by pituitary activin/BMP systems using a mouse gonadotropinoma cell line Lβ T2, which expresses activin/BMP receptors, transcription factor Smads, PPARα , and PPARγ . In Lβ T2 cells, BMP signaling shown by Smad1/5/8 phosphorylation and Id-1 transcription was readily activated by BMPs. A PPARγ agonist, pioglitazone significantly reduced BMP-induced DNA synthesis by Lβ T2; whereas the PPARα agonist, fenofibric acid, did not. In accordance with the effects on cell mitosis, pioglitazone but not fenofibric acid significantly decreased BMP-induced Id-1-Luc activation. Neither fenofibric acid nor pioglitazone affected activin signaling detected by (CAGA)9-Luc activity. Both PPARα and PPARγ ligands directly suppressed transcriptional activities of FSHβ , LHβ , and GnRHR. Activation of PPARα and PPARγ increased mRNA levels of follistatin, but did not affect the expression of follistatin-related gene. Thus, PPAR agonists not only directly suppress gonadotropin transcription and BMP signaling, but also inhibit the biological actions of activins which facilitate gonadotropin transcription through upregulating follistatin expression. In addition, pioglitazone increased BMP ligands mRNA, but decreased activin-β B mRNA in Lβ T2 cells. Collectively, PPAR activation differentially regulates gonadotrope cell proliferation and gonadotropin transcription in a ligand-dependent manner.
